Versican Plus DHPPi/L4R

Name of medicine: Versican Plus DHPPi/L4R
Active substance: canine distemper virus, strain CDV Bio 11/A, canine adenovirus type 2, strain CAV-2 Bio 13, canine parvovirus type 2b, strain CPV-2b Bio 12/B, canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (all live attenuated), Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L. interrogans serogroup Canicola serovar Canicola, strain MSLB 1090, L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091...
International non-proprietary name (INN) or common name: live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated and Leptospira

live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira
Immunologicals for canidae

Authorisation details

Versican Plus DHPPi/L4R : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (81.94 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά: 13/04/2015 Τελευταία ενημέρωση: 14/10/2024

CVMP post-authorisation summary of positive opinion for Versican Plus DHPPi/L4R

Adopted Reference Number: EMA/CVMP/574869/2018

English (EN) (69.4 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά: 14/09/2018 Τελευταία ενημέρωση: 14/09/2018

Versican Plus DHPPi/L4R : EPAR - Public assessment report

Adopted

English (EN) (81.49 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά: 11/08/2014 Τελευταία ενημέρωση: 14/10/2024

CVMP summary of positive opinion for Versican Plus DHPPi/L4R

Adopted Reference Number: EMA/CVMP/92024/2014

English (EN) (80.47 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά: 14/03/2014 Τελευταία ενημέρωση: 14/03/2014

This page was last updated on 14/10/2024